Activation of ExoU phospholipase activity requires specific C-terminal regions

Journal of Bacteriology

Volumn 192, Issue 7, 2010, Pages 1801-1812

  Schmalzer, Katherine M ^a   Benson, Marc A ^a,b   Frank, Dara W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL ENZYME; EXOU PHOSPHOLIPASE; PHOSPHOLIPASE A2; RECOMBINANT PROTEIN; SOD1; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CYTOARCHITECTURE; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTIC CELL; EXPRESSION VECTOR; GENOTYPE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; SCREENING; TISSUE CULTURE; TRANSPOSON; WESTERN BLOTTING;

BACTERIAL PROTEINS; COENZYMES; DNA TRANSPOSABLE ELEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; MUTAGENESIS, INSERTIONAL; PHOSPHOLIPASES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SUPEROXIDE DISMUTASE;

EUKARYOTA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 77949694407     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.00904-09     Document Type: Article

References (57)

1. Benson, M. A., K. M. Schmalzer, and D. W. Frank. 2010. A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity. Clin. Chim. Acta 411:190-197.
2. Bharathi, M. J., R. Ramakrishnan, R. Meenakshi, C. S. Kumar, S. Padmavathy, and S. Mittal. 2007. Ulcerative keratitis associated with contact lens wear. Indian J. Ophthalmol. 55:64-67.
3. Bjarnsholt, T., P. O. Jensen, M. J. Fiandaca, J. Pedersen, C. R. Hansen, C. B. Andersen, T. Pressler, M. Givskov, and N. Hoiby. 2009. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44:547-558.
4. Chang, L. Y., J. W. Slot, H. J. Geuze, and J. D. Crapo. 1988. Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes. J. Cell Biol. 107:2169-2179.
5. Dessen, A., J. Tang, H. Schmidt, M. Stahl, J. D. Clark, J. Seehra, and W. S. Somers. 1999. Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism. Cell 97:349-360.
6. Diaz, M. H., C. M. Shaver, J. D. King, S. Musunuri, J. A. Kazzaz, and A. R. Hauser. 2008. Pseudomonas aeruginosa induces localized immunosuppression during pneumonia. Infect. Immun. 76:4414-4421.
7. Finck-Barbançon, V., and D. W. Frank. 2001. Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU. J. Bacteriol. 183: 4330-4344.
8. Finck-Barbançon, V., J. Goranson, L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M. Fleiszig, C. Wu, L. Mende-Mueller, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-557.
9. Finck-Barbançon, V., T. L. Yahr, and D. W. Frank. 1998. Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin. J. Bacteriol. 180:6224-6231.
10. Fleiszig, S. M., N. Efron, and G. B. Pier. 1992. Extended contact lens wear enhances Pseudomonas aeruginosa adherence to human corneal epithelium. Investig. Ophthalmol. Vis. Sci. 33:2908-2916.
11. Fleiszig, S. M., J. P. Wiener-Kronish, H. Miyazaki, V. Vallas, K. E. Mostov, D. Kanada, T. Sawa, T. S. Yen, and D. W. Frank. 1997. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect. Immun. 65:579-586.
12. Frank, D. W., A. Vallis, J. P. Wiener-Kronish, A. Roy-Burman, E. G. Spack, B. P. Mullaney, M. Megdoud, J. D. Marks, R. Fritz, and T. Sawa. 2002. Generation and characterization of a protective monoclonal antibody to Pseudomonas aeruginosa PcrV. J. Infect. Dis. 186:64-73.
13. Fu, H., J. Coburn, and R. J. Collier. 1993. The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family. Proc. Natl. Acad. Sci. U. S. A. 90:2320-2324.
14. Galan, J. E., and H. Wolf-Watz. 2006. Protein delivery into eukaryotic cells by type III secretion machines. Nature 444:567-573.
15. Garrity-Ryan, L., B. Kazmierczak, R. Kowal, J. Comolli, A. Hauser, and J. N. Engel. 2000. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 68:7100-7113.
16. Garrity-Ryan, L., S. Shafikhani, P. Balachandran, L. Nguyen, J. Oza, T. Jakobsen, J. Sargent, X. Fang, S. Cordwell, M. A. Matthay, and J. N. Engel. 2004. The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities. Infect. Immun. 72:546-558.
17. Gillis, R. J., K. G. White, K. H. Choi, V. E. Wagner, H. P. Schweizer, and B. H. Iglewski. 2005. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 49:3858-3867.
18. Hartfield, P. J., and J. M. Robinson. 1998. Arachidonic acid activates NADPH oxidase by a direct, calmodulin-regulated mechanism. Prostaglandins Other Lipid Mediat. 56:1-6.
19. Hauser, A. R., E. Cobb, M. Bodi, D. Mariscal, J. Valles, J. N. Engel, and J. Rello. 2002. Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Crit. Care Med. 30:521-528.
20. Hauser, A. R., and J. N. Engel. 1999. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells. Infect. Immun. 67:5530-5537.
21. Hentzer, M., H. Wu, J. B. Andersen, K. Riedel, T. B. Rasmussen, N. Bagge, N. Kumar, M. A. Schembri, Z. Song, P. Kristoffersen, M. Manefield, J. W. Costerton, S. Molin, L. Eberl, P. Steinberg, S. Kjelleberg, N. Hoiby, and M. Givskov. 2003. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22:3803-3815.
22. Huigens, R. W., J. J. Richards, G. Parise, T. E. Ballard, W. Zeng, R. Deora, and C. Melander. 2007. Inhibition of Pseudomonas aeruginosa biofilm formation with Bromoageliferin analogues. J. Am. Chem. Soc. 129:6966-6967.
23. Iglewski, B. H., J. Sadoff, M. J. Bjorn, and E. S. Maxwell. 1978. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc. Natl. Acad. Sci. U. S. A. 75:3211-3215.
24. Kinnula, V. L., and J. D. Crapo. 2003. Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 167:1600-1619.
25. Krall, R., J. Sun, K. J. Pederson, and J. T. Barbieri. 2002. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infect. Immun. 70:360-367.
26. Kuehl, F. A. J., and R. W. Egan. 1980. Prostaglandins, arachidonic acid, and inflammation. Science 210:978-984.
27. Lambert, P. A. 2002. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J. R Soc. Med. 95(Suppl. 41):22-26.
28. Maniatis, T., J. Sambrook, and E. F. Fritsch. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Marketon, M. M., R. W. DePaolo, K. L. DeBord, B. Jabri, and O. Schneewind. 2005. Plague bacteria target immune cells during infection. Science 309:1739-1741.
30. Marklund, S. L. 1984. Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Investig. 74:1398-1403.
31. Marklund, S. L. 1984. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 222:649-655.
32. Mueller, C. A., P. Broz, and G. R. Cornelis. 2008. The type III secretion system tip complex and translocon. Mol. Microbiol. 68:1085-1095.
33. Olsen, R. H., G. DeBusscher, and W. R. McCombie. 1982. Development of broad-host-range vectors and gene banks: self-cloning of the Pseudomonas aeruginosa PAO chromosome. J. Bacteriol. 150:60-69.
34. Phillips, R. M., D. A. Six, E. A. Dennis, and P. Ghosh. 2003. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 278:41326-41332.
35. Pirnay, J. P., D. De Vos, C. Cochez, F. Bilocq, J. Pirson, M. Struelens, L. Duinslaeger, P. Cornelis, M. Zizi, and A. Vanderkelen. 2003. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J. Clin. Microbiol. 41:1192-1202.
36. Rabin, S. D., and A. R. Hauser. 2005. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect. Immun. 73:573-582.
37. Rabin, S. D., J. L. Veesenmeyer, K. T. Bieging, and A. R. Hauser. 2006. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells. Infect. Immun. 74:2552-2561.
38. Rae, T. D., P. J. Schmidt, R. A. Pufahl, V. C. Culotta, and T. V. O'Halloran. 1999. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284:805-808.
39. Roy-Burman, A., R. H. Savel, S. Racine, B. L. Swanson, N. S. Revadigar, J. Fujimoto, T. Sawa, D. W. Frank, and J. P. Wiener-Kronish. 2001. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J. Infect. Dis. 183:1767-1774.
40. Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171:1209-1223.
41. Sadikot, R. T., H. Zeng, A. C. Azim, M. Joo, S. K. Dey, R. M. Breyer, R. S. Peebles, T. S. Blackwell, and J. W. Christman. 2007. Bacterial clearance of Pseudomonas aeruginosa is enhanced by the inhibition of COX-2. Eur. J. Immunol. 37:1001-1009.
42. Saliba, A. M., M. C. de Assis, R. Nishi, B. Raymond, A. Marques Ede, U. G. Lopes, L. Touqui, and M. C. Plotkowski. 2006. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU. Microbes Infect. 8:450-459.
43. Sato, H., J. B. Feix, and D. W. Frank. 2006. Identification of superoxide dismutase as a cofactor for the Pseudomonas type III toxin, ExoU. Biochemistry 45:10368-10375.
44. Sato, H., and D. W. Frank. 2004. ExoU is a potent intracellular phospholipase. Mol. Microbiol. 53:1279-1290.
45. Sato, H., and D. W. Frank. 2007. Type III secretory proteins in Pseudomonas aeruginosa, p. 3-22. In Brogden, K. A., F. C. Minion, N. Cornick, T. Stanton, Q. Zhang, L. K. Nolan, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogens, 4th ed. ASM Press, Washington, DC.
46. Sato, H., D. W. Frank, C. J. Hillard, J. B. Feix, R. R. Pankhaniya, K. Moriyama, V. Finck-Barbancon, A. Buchaklian, M. Lei, R. M. Long, J. Wiener-Kronish, and T. Sawa. 2003. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 22:2959-2969.
47. Sawa, T., T. L. Yahr, M. Ohara, K. Kurahashi, M. A. Gropper, J. P. Wiener-Kronish, and D. W. Frank. 1999. Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury. Nat. Med. 5:392-398.
48. Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-121.
49. Shaver, C. M., and A. R. Hauser. 2006. Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology 152:143-152.
50. Studier, F. W., and B. A. Moffatt. 1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130.
51. Sun, J., and J. T. Barbieri. 2003. Pseudomonas aeruginosa ExoT ADPribosylates CT10 regulator of kinase (Crk) proteins. J. Biol. Chem. 278: 32794-32800.
52. Tateda, K., R. Comte, J. C. Pechere, T. Kohler, K. Yamaguchi, and C. Van Delden. 2001. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:1930-1933.
53. Vallis, A. J., V. Finck-Barbancon, T. L. Yahr, and D. W. Frank. 1999. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect. Immun. 67:2040-2044.
54. Verhelst, D., C. Koppen, J. Van Looveren, A. Meheus, and M. J. Tassignon. 2006. Contact lens-related corneal ulcers requiring hospitalization: a 7-year retrospective study in Belgium. Acta Ophthalmol. Scand. 84:522-526.
55. Vogel, H. J., and D. M. Bonner. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
56. Yahr, T. L., J. T. Barbieri, and D. W. Frank. 1996. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. J. Bacteriol. 178:1412-1419.
57. Yahr, T. L., A. J. Vallis, M. K. Hancock, J. T. Barbieri, and D. W. Frank. 1998. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc. Natl. Acad. Sci. U. S. A. 95:13899-13904.